| Humoral-and T-cell–specific immune responses to SARS-CoV-2 mRNA vaccination in patients with MS using different disease-modifying therapies C Tortorella, A Aiello, C Gasperini, C Agrati, C Castilletti, S Ruggieri, ... Neurology 98 (5), e541-e554, 2022 | 144 | 2022 |
| A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients L Petrone, E Petruccioli, V Vanini, G Cuzzi, SN Fard, T Alonzi, C Castilletti, ... Clinical microbiology and infection 27 (2), 286. e7-286. e13, 2021 | 131 | 2021 |
| First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus E Petruccioli, T Chiacchio, I Pepponi, V Vanini, R Urso, G Cuzzi, ... Journal of Infection 73 (6), 588-597, 2016 | 123 | 2016 |
| Mycobacterium tuberculosis DNA detection in soluble fraction of urine from pulmonary tuberculosis patients A Cannas, D Goletti, E Girardi, T Chiacchio, L Calvo, G Cuzzi, ... The international journal of tuberculosis and lung disease 12 (2), 146-151, 2008 | 122 | 2008 |
| Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients T Chiacchio, E Petruccioli, V Vanini, G Cuzzi, C Pinnetti, A Sampaolesi, ... Journal of Infection 69 (6), 533-545, 2014 | 118 | 2014 |
| Analytical evaluation of QuantiFERON-Plus and QuantiFERON-Gold In-tube assays in subjects with or without tuberculosis E Petruccioli, V Vanini, T Chiacchio, G Cuzzi, DM Cirillo, F Palmieri, ... Tuberculosis 106, 38-43, 2017 | 114 | 2017 |
| Quantitative and qualitative profiles of circulating monocytes may help identifying tuberculosis infection and disease stages MP La Manna, V Orlando, F Dieli, P Di Carlo, A Cascio, G Cuzzi, ... PloS one 12 (2), e0171358, 2017 | 114 | 2017 |
| Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders G Delogu, T Chiacchio, V Vanini, O Butera, G Cuzzi, A Bua, P Molicotti, ... PloS one 6 (3), e18315, 2011 | 90 | 2011 |
| IP-10 detection in urine is associated with lung diseases A Cannas, L Calvo, T Chiacchio, G Cuzzi, V Vanini, FN Lauria, L Pucci, ... BMC infectious diseases 10, 1-8, 2010 | 87 | 2010 |
| Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2 L Petrone, E Petruccioli, V Vanini, G Cuzzi, G Gualano, P Vittozzi, ... International journal of infectious diseases 113, S82-S87, 2021 | 85 | 2021 |
| IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country V Vanini, E Petruccioli, C Gioia, G Cuzzi, N Orchi, A Rianda, L Alba, ... Journal of infection 65 (1), 49-59, 2012 | 83 | 2012 |
| ImmunosuppressiveTherapies differently modulate Humoral-and T-cell-specific responses to COVID-19 mRNA vaccine in rheumatoid arthritis patients A Picchianti-Diamanti, A Aiello, B Laganà, C Agrati, C Castilletti, S Meschi, ... Frontiers in immunology 12, 740249, 2021 | 82 | 2021 |
| Higher frequency of T-cell response to M. tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral blood T Chiacchio, E Petruccioli, V Vanini, O Butera, G Cuzzi, L Petrone, ... PLoS One 6 (11), e27539, 2011 | 71 | 2011 |
| Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis E Petruccioli, L Petrone, V Vanini, G Cuzzi, A Navarra, G Gualano, ... Journal of Infection 71 (5), 526-533, 2015 | 63 | 2015 |
| Blood and urine inducible protein 10 as potential markers of disease activity L Petrone, A Cannas, V Vanini, G Cuzzi, F Aloi, M Nsubuga, ... The International Journal of Tuberculosis and Lung Disease 20 (11), 1554-1561, 2016 | 60 | 2016 |
| In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy L Petrone, E Petruccioli, T Alonzi, V Vanini, G Cuzzi, SN Fard, C Castilletti, ... Journal of Infection 82 (4), 58-66, 2021 | 47 | 2021 |
| Sporadic hepatitis C virus infection: a case-control study of transmission routes in a selected hospital sample of the general population in Italy UV Comandini, G Tossini, MA Longo, F Ferri, G Cuzzi, P Noto, ... Scandinavian journal of infectious diseases 30 (1), 11-15, 1998 | 46 | 1998 |
| Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients A Aiello, SN Fard, E Petruccioli, L Petrone, V Vanini, C Farroni, G Cuzzi, ... International Journal of Infectious Diseases 106, 338-347, 2021 | 45 | 2021 |
| Kinetics of the B-and T-cell immune responses after 6 months from SARS-CoV-2 mRNA vaccination in patients with rheumatoid arthritis C Farroni, A Picchianti-Diamanti, A Aiello, E Nicastri, B Laganà, C Agrati, ... Frontiers in immunology 13, 846753, 2022 | 42 | 2022 |
| Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection E Petruccioli, T Chiacchio, A Navarra, V Vanini, G Cuzzi, C Cimaglia, ... Journal of Infection 80 (5), 536-546, 2020 | 42 | 2020 |
